Tight control of the APP-Mint1 interaction in regulating amyloid production
Shawna M. HenryiD, Sabrina A. KistleriD, Gavin D. LaganiiD, Christian R. O. BartlingiD, Dennis ÖzcelikiD, Vita SereikaitéiD, Kristian StrømgaardiD, Uwe BeffertiD, Angela HoiD
Abstract
Generation of amyloid-beta (A{beta}) peptides through the proteolytic processing of the amyloid precursor protein (APP) is one pathogenic event in Alzheimers disease (AD). APP is a type I transmembrane protein and endocytosis of APP mediated by the endocytic YENPTY sequence is a key step in A{beta} generation. We and others have found that Mints, a family of cytosolic adaptor proteins, directly binds to the YENPTY motif of APP via phosphotyrosine binding (PTB) domain of Mints, facilitates APP trafficking and processing. We also show mutation of Tyr633 of Mint1 (Mint1Y633A) enhances APP binding and processing. Now, we created a low-affinity Mint1 mutant that targets two conserved residues, Tyr549 and Phe610 (Mint1Y549A/F610A), that reduced APP binding. Here, we investigate how perturbing the APP-Mint1 interaction alters APP and Mint1 cellular dynamics as well as Mint1s interaction with its other binding partners. We show that Mint1Y633A increased binding affinity specifically for APP and presenilin1, enhanced APP endocytosis, and A{beta} secretion in primary neurons. Conversely, Mint1Y549A/F610A exhibited reduced APP affinity and A{beta} secretion. In fact, the effect of Mint1Y549A/F610A on A{beta} release was greater compared to knocking down all three Mint proteins, supporting targeting APP-Mint1 interaction as a potential AD therapeutic.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.18
- Field percentile
- 49th percentile
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA.
Jordan M Krupa, Abdul M. Naqvi, … Stephen Pasternak·bioRxiv·Mar 2, 2025
- MT5-MMP controls APP metabolism and the fate of beta-CTF/C99 and Abeta through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease
Laura García‐González, Jean‐Michel Paumier, … Santiago Rivera·The FASEB JournalPeer-reviewed·Jun 12, 2021
- Levetiracetam treatment normalizes levels of the presynaptic endocytosis machinery and restores non-amyloidogenic APP processing in App knock-in mice.
Nalini R. Rao, Jeffrey N. Savas·Journal of Proteome ResearchPeer-reviewed·Jun 9, 2021
- MT5-MMP C-terminal mutations reduce C99 and β accumulation: A foundation for peptide-based Alzheimer's interventions
Pedro Belio Mairal, Athina Kamitsou, … Santiago Rivera·bioRxiv·May 22, 2025
- RABGAP1 acts as a sensor to facilitate sorting and processing of amyloid precursor protein
Jessica Eden, Jonathan G. G. Kaufman, … David C. Gershlick·The EMBO JournalPeer-reviewed·Aug 26, 2025
- Aβ promotes amyloidogenic processing of APP through a Go/Gβγ signaling
Magdalena Antonino, Paula Marmo, … Elena Anahí Bignante·bioRxiv·Mar 10, 2021